Literature DB >> 8246154

Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.

R K Zalups1.   

Abstract

The effects of the water-soluble chelating agents 2,3-dimercapto-1-propane sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of inorganic mercury were studied in normal and uninephrectomized (NPX) rats injected (i.v.) with a nontoxic 0.5-mumol/kg dose of mercuric chloride (HgCl2). When a 100-mg/kg dose of either DMPS or DMSA was injected (i.p.) 24 and 30 hr after treatment with HgCl2, the renal concentration and burden of inorganic mercury decreased markedly in both normal and NPX rats during the 24 hr after the first dose of the respective chelating agent was administered. Treatment with DMPS was more effective than treatment with DMSA in reducing the renal burden of mercury in both groups of rats. The fall in the renal concentration and burden of mercury in both normal and NPX rats was due primarily to a decrease in the content of mercury in the renal cortex and outer stripe of the outer medulla. However, the decrease in the concentration of inorganic mercury in the outer stripe was significantly greater in NPX rats than in normal rats. Both chelating agents caused urinary excretion of mercury to increase significantly in normal and NPX rats. In association with the increased renal release of mercury in NPX rats, the urinary excretion of mercury per gram of kidney was significantly greater in NPX rats than in normal rats. These data indicate that the renal handling of DMPS and DMSA may be altered significantly after a substantial reduction in renal mass. Findings from the present study also show that treatment with DMPS, but not with DMSA, causes the content of mercury in the liver and cellular fraction of blood to decrease in normal and NPX rats. These findings indicate that there are significant differences in the extrarenal handling of these two chelating agents. The findings in the present study suggest that DMPS and DMSA are very effective agents in reducing the renal (and whole body) burden of inorganic mercury in normal and NPX rats.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8246154

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

Review 1.  Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.

Authors:  Rudolfs K Zalups; Christy C Bridges
Journal:  Chem Res Toxicol       Date:  2012-06-15       Impact factor: 3.739

2.  Novel Hg2+-induced nephropathy in rats and mice lacking Mrp2: evidence of axial heterogeneity in the handling of Hg2+ along the proximal tubule.

Authors:  Rudolfs K Zalups; Lucy Joshee; Christy C Bridges
Journal:  Toxicol Sci       Date:  2014-08-21       Impact factor: 4.849

Review 3.  The aging kidney and the nephrotoxic effects of mercury.

Authors:  Christy C Bridges; Rudolfs K Zalups
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-02-07       Impact factor: 6.393

4.  Effect of mercuric chloride on various hydroxyproline fractions in rat serum.

Authors:  N J Siddiqi; A S Alhomida
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

5.  MRP2 and the handling of mercuric ions in rats exposed acutely to inorganic and organic species of mercury.

Authors:  Christy C Bridges; Lucy Joshee; Rudolfs K Zalups
Journal:  Toxicol Appl Pharmacol       Date:  2010-12-04       Impact factor: 4.219

6.  Aging and the disposition and toxicity of mercury in rats.

Authors:  Christy C Bridges; Lucy Joshee; Rudolfs K Zalups
Journal:  Exp Gerontol       Date:  2014-02-16       Impact factor: 4.032

7.  Effect of DMPS and DMSA on the placental and fetal disposition of methylmercury.

Authors:  C C Bridges; L Joshee; R K Zalups
Journal:  Placenta       Date:  2009-07-16       Impact factor: 3.481

8.  Efficacy of DMSA Therapy in a Sample of Arab Children with Autistic Spectrum Disorder.

Authors:  Eleonor Blaucok-Busch; Omnia R Amin; Hani H Dessoki; Thanaa Rabah
Journal:  Maedica (Buchar)       Date:  2012-09

9.  Multidrug resistance proteins and the renal elimination of inorganic mercury mediated by 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid.

Authors:  Christy C Bridges; Lucy Joshee; Rudolfs K Zalups
Journal:  J Pharmacol Exp Ther       Date:  2007-10-16       Impact factor: 4.030

10.  The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels.

Authors:  J B Adams; M Baral; E Geis; J Mitchell; J Ingram; A Hensley; I Zappia; S Newmark; E Gehn; R A Rubin; K Mitchell; J Bradstreet; J M El-Dahr
Journal:  J Toxicol       Date:  2009-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.